AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 181 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.21 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $250,880 | +1178.7% | 5,818 | +767.1% | 0.00% | – |
Q1 2024 | $19,620 | +45.9% | 671 | +11.1% | 0.00% | – |
Q4 2023 | $13,450 | -75.8% | 604 | -73.1% | 0.00% | – |
Q3 2023 | $55,548 | -32.4% | 2,243 | -24.1% | 0.00% | – |
Q2 2023 | $82,170 | -92.8% | 2,955 | -94.1% | 0.00% | -100.0% |
Q1 2023 | $1,144,823 | +7.9% | 49,840 | +31.9% | 0.00% | 0.0% |
Q4 2022 | $1,060,636 | +12.6% | 37,772 | +13.3% | 0.00% | 0.0% |
Q3 2022 | $942,000 | +9.3% | 33,346 | -14.5% | 0.00% | 0.0% |
Q2 2022 | $862,000 | -32.1% | 38,989 | -10.7% | 0.00% | 0.0% |
Q1 2022 | $1,269,000 | -34.1% | 43,637 | -25.5% | 0.00% | -33.3% |
Q4 2021 | $1,925,000 | -61.1% | 58,600 | -45.4% | 0.00% | -62.5% |
Q3 2021 | $4,949,000 | -35.8% | 107,294 | -23.3% | 0.01% | -38.5% |
Q2 2021 | $7,704,000 | +28.4% | 139,847 | +20.3% | 0.01% | +18.2% |
Q1 2021 | $6,002,000 | -7.6% | 116,259 | -22.5% | 0.01% | -15.4% |
Q4 2020 | $6,495,000 | +94.5% | 149,937 | +56.8% | 0.01% | +85.7% |
Q3 2020 | $3,340,000 | +53.1% | 95,602 | +133.9% | 0.01% | +40.0% |
Q2 2020 | $2,182,000 | +12735.3% | 40,866 | +8326.0% | 0.01% | – |
Q1 2020 | $17,000 | +112.5% | 485 | +325.4% | 0.00% | – |
Q1 2019 | $8,000 | +60.0% | 114 | 0.0% | 0.00% | – |
Q4 2018 | $5,000 | -76.2% | 114 | -58.8% | 0.00% | – |
Q3 2018 | $21,000 | -8.7% | 277 | 0.0% | 0.00% | – |
Q2 2018 | $23,000 | 0.0% | 277 | 0.0% | 0.00% | – |
Q1 2018 | $23,000 | +666.7% | 277 | +515.6% | 0.00% | – |
Q4 2017 | $3,000 | -96.7% | 45 | -96.7% | 0.00% | – |
Q3 2017 | $91,000 | -21.6% | 1,364 | -39.3% | 0.00% | – |
Q2 2017 | $116,000 | -22.1% | 2,247 | -11.8% | 0.00% | – |
Q1 2017 | $149,000 | +254.8% | 2,549 | +163.9% | 0.00% | – |
Q4 2016 | $42,000 | – | 966 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |